CAFs senescence-associated risk signature

There is 1 paper on CAFs senescence-associated risk signature in aging research: none in people yet, 1 in cells.

Biomarker

1 paper studies it2 findings

See all 1 papers on CAFs senescence-associated risk signature

  • Cells1

Effects

2

Immunotherapy response

downin silico1

1 study
  1. CAFs senescence-associated risk signature decreases immunotherapy response in silico (bioinformatics analysis).

    In silicobioinformatics analysis

Prognosis

downin silico1

1 study
  1. CAFs senescence-associated risk signature impairs prognosis in training and validation cohorts.

    In silicoin training and validation cohorts

Latest